Table 3

Chemotherapy Associated With Hypertension

Chemotherapy AgentsIncidenceFrequency of Use
Monoclonal antibody-based tyrosine kinase inhibitor
 Bevacizumab (Avastin) (18,19,107–112)4–35++
Small molecule tyrosine kinase inhibitors
 Sorafenib (Nexavar) (96,113–116)17–43+++
 Sunitinib (Sutent) (37,118–122)5–47+++

For an explanation of the + symbols, please see Table 1. Medication manufacturers and locations as in Tables 1 and 2.